CANLI
Yükleniyor Veriler getiriliyor…
/ Makaleler / Scopus Detay
Scopus YÖKSİS DOI Eşleşti SJR Q3

Anti-saccharomyces cerevisiae as unusual antibody in autoimmune polyglandular syndrome type III: A case report

Endocrine Metabolic and Immune Disorders Drug Targets · Ocak 2019

Özet
Backgraund and Objective: Anti-Saccharomyces Cerevisiae Antibodies (ASCA) that are considered to reflect immune response against increased intestinal permeability due to mucosal damage are among the serological markers of Crohn’s Disease. Methods: This microbial seromarker was recently shown to be elevated in several autoimmune disorders such as celiac disease, autoimmune liver diseases, type 1 diabetes, and Graves’ disease. Despite that fact, ASCA seropositivity in Autoimmune Polyglandular Syndrome (APS) has never been reported before. Results: Herein, we present a 46-year-old woman who has uveitis, autoimmune thyroiditis, and primary ovarian failure. Conclusion: Based on the coexistence of these diseases, the patient was diagnosed with APS type III. Moreover, ASCA seropositivity was detected although she has no overt intestinal disease.
0 atıf Ocak 2019 DOI
YÖKSİS DOI Eşleşmesi Bulundu

Bu Scopus makalesi YÖKSİS veritabanında da kayıtlı. Aşağıda YÖKSİS verilerini görebilirsiniz.

YÖKSİS Kayıtları
Anti-Saccharomyces Cerevisiae as Unusual Antibody in Autoimmune Polyglandular Syndrome Type III: A Case Report
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS · 2019 SCI-Expanded
Dr. Öğr. Üyesi AHMET GÖRGEL →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 3 kaydı bulundu.
Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade
2017 ISSN: 18715303 SCI-Expanded
Doç. Dr. KADRİ MURAT GÜRSES →
Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade
2017 ISSN: 18715303 SCI-Expanded Q4
Doç. Dr. MUHAMMED ULVİ YALÇIN →
Anti-Saccharomyces Cerevisiae as Unusual Antibody in Autoimmune Polyglandular Syndrome Type III: A Case Report
2019 ISSN: 1871-5303 SCI-Expanded Q3
Dr. Öğr. Üyesi AHMET GÖRGEL →

Makale Bilgileri

Toplam Atıf 0 atıf · Scopus
ISSN18715303
Yayın TarihiOcak 2019
Cilt / Sayfa19 · 90-94

Kurumlar

Gozde Academy Hospital Malatya
Malatya Turkey

Havuzumuzdaki Atıflar 0

Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır.

Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
Endocrine, Metabolic and Immune Disorders - Drug Targets
Q3
SJR Skoru0,552
H-Index69
YayıncıBentham Science Publishers
ÜlkeUnited Arab Emirates
Endocrinology, Diabetes and Metabolism (Q3)
Immunology and Allergy (Q3)
Dergi sayfasına git

Sistemimizdeki Yazarlar